Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: NIL: NA
Control Intervention1: NIL: NA
Sponsors
Jawaharlal Nehru Medical College , Datta Meghe Institute of Higher education and reserach
Acharaya Vinobha Bhave Rural Hospital
Eligibility
Inclusion criteria
Inclusion criteria: All admitted patients with histopathologically proven and confirmed diagnosis of breast cancer, above 18 years of age
Exclusion criteria
Exclusion criteria: Patients taking discharge before completing treatment or transferred to another hospital Patients who are being treated with anticoagulants or antiplatelet drugs (such as heparin, aspirin, or hemocoagulase) Patients having previous history of coagulopathy (DVT, PE) Patients with severe liver diseases Patients having coagulation disorders (hemophilia/ vit K disorders) Patients not consenting to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased Risk of Thrombosis Altered Coagulation Parameters Platelets Coagulation Factors Fibrinogen Increased Bleeding Risk Impact of Specific Drugs Interaction with Anticoagulants Monitoring and Management Timepoint: Assessment of parameters will be done after each cycle of chemotherapy until 6 cycles | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Swati Deshpande
Datta Meghe Institute of higher education and research
Outcome results
None listed